Iclusig

Made by

• Otsuka Pharmaceutical

Active Ingredient

Ponatinib hydrochloride

Prospectus

Approval date

2016/9/28

Treats

• B-cell acute lymphoblastic leukemia, B-cell acute lymphocytic leukemia
• Chronic myeloid leukemia

Dosages

• ICLUSIG tablets 15mg - 6428.4円／錠